Pharmacological effects of Ivosidenib

Ivosidenib (Ivosidenib) is an IDH1 inhibitor that acts on subtypes of IDH1 gene mutations that are expressed in patients with certain cancers such as leukemia. Its pharmacological effects are mainly focused on inhibiting the abnormal activation of isocitrate dehydrogenase 1 (IDH1).

IDH1 is an enzyme involved in cell metabolism and helps cells produce energy under normal circumstances. However, in some cancers, especially acute myeloid leukemia (AML), the IDH1 gene may be mutated, leading to abnormal activation of the IDH1 enzyme. This mutation leads to abnormalities in cellular metabolic pathways and promotes the growth and proliferation of cancer cells.

Avosidenib interferes with the metabolic process in cancer cells by specifically inhibiting the abnormal activity ofIDH1 enzyme. Specifically, it blocks the process by which IDH1 enzyme converts isocitrate into α-ketoglutarate, preventing it from participating in normal metabolic pathways. Such inhibition helps slow or stop the growth and proliferation of cancer cells caused by IDH1 mutations, ultimately achieving therapeutic effects.

The pharmacological effects of ivonib are highly specific and mainly act on cancer cells expressing IDH1 gene mutations, reducing the adverse effects on normal cells. This targeted therapy strategy makes it an innovative approach to leukemia treatment that offers hope to some patients, especially those whose needs are not being met by traditional treatments.

Avosidenib is already on the market in China, but it has not yet been included in medical insurance. The price of Avosidenib on the domestic market is very high, reaching tens of thousands of yuan. For specific prices, please consult the local hospital pharmacy. The price of the American original drug of Ivonib abroad is as high as hundreds of thousands. Currently, there are generic drugs of Ivonib on the market, mainly Laos generic drugs, which cost about 10,000 yuan, which is much cheaper in comparison, and the ingredients of the original drug and the generic drug are basically the same.